Abviva receives new patent grant notifications for MSA technology Abviva.

, a biomedical organization involved in the commercialization and development of breast cancers related applications of Mammastatin, today provided further information regarding worldwide patent protection because of its breast cancers risk assessment technology. The patents will be the most recent of 13 worldwide and U.S. Patents to issue to the University of Michigan for breast tumor diagnostic and therapeutic uses of Mammastatin. Related StoriesOvarian cancer sufferers with a brief history of oral contraceptive use have got better outcomesMD Anderson study reveals why chemotherapy medications not effective for most pancreatic malignancy patientsCornell biomedical engineers develop 'super natural killer cells' to destroy tumor cells in lymph nodesThe international patents detail ways of make use of and compositions of Mammastatin in therapeutic and diagnostic applications in the United States , Australia , Canada , European countries , and Japan .You will see the entire Kaiser Daily Health Policy Record, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Kaiser Daily Health Policy Report is released for Kaisernetwork.org, a free of charge services of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Business and Kaiser Family Base. All rights reserved.. Kathryn M. Edwards, M.D., Yuwei Zhu, M.D., Marie R. Griffin, M.D., M.P.H., Geoffrey A. Weinberg, M.D., Caroline B. Hall, M.D., Peter G. Szilagyi, M.D., M.P.H., Mary A. Staat, M.D., M.P.H., Marika Iwane, Ph.D., M.P.H., Mila M. Prill, M.S.P.H., and John V. Williams, M.D. For the New Vaccine Surveillance Network: Burden of Human Metapneumovirus Infection in Young Children Human metapneumovirus , a paramyxovirus discovered in 2001, is connected with severe respiratory illness among infants and children worldwide.1-11 In addition, HMPV causes acute respiratory results and disease in hospitalization among older adults and people with underlying chronic circumstances, including asthma, cancer, and chronic obstructive pulmonary disease.12-19 However, the seasonality of HMPV disease and its own overall burden in hospitalizations and outpatient visits among small children remain poorly defined.